Related Experiment Videos
Innovative drug treatments for viral and autoimmune myocarditis
S Anandasabapathy1, W H Frishman
1Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York, USA.
Abstract:
Myocarditis has been shown to be a common cause of cardiomyopathy and is believed to account for 25% of all cases in human beings. Unfortunately, the disease is difficult to detect before a myopathic process ensues. Treatment of myocarditis-induced heart failure includes the standard regimen of diuretics, digoxin, angiotensin-converting enzyme inhibitors, and currently, beta-adrenergic blockers. Treatment of myocarditis itself is dependent on the etiology of the illness. Treatments under investigation include immunosuppressants, nonsteroidal antiinflammatory agents, immunoglobulins, immunomodulation, antiadrenergics, calcium-channel blockers, angiotensin-converting enzyme inhibitors, nitric oxide inhibition (e.g., aminoguanidine), and antiviral agents. Despite advances in treatment, more work needs to be done in the early detection of myocarditis. Additionally, better means need to be established for distinguishing between viral and autoimmune forms of the disease, so that appropriate treatment can be instituted.
Insights
Myocarditis, a common cause of cardiomyopathy, is difficult to detect early. Further research is needed for early detection and differentiating viral from autoimmune causes for effective treatment.
Area of Science:
- Cardiology
- Immunology
Background:
- Myocarditis is a significant cause of cardiomyopathy, responsible for approximately 25% of human cases.
- Early detection of myocarditis before significant myocardial damage occurs remains a clinical challenge.
Purpose of the Study:
- To review current understanding and treatment strategies for myocarditis.
- To highlight the need for improved diagnostic methods and etiological differentiation.
Main Methods:
- Literature review of myocarditis etiology, diagnosis, and treatment.
- Analysis of standard and investigational therapeutic approaches.
Main Results:
- Standard heart failure management for myocarditis includes diuretics, digoxin, ACE inhibitors, and beta-blockers.
- Investigational treatments encompass immunosuppressants, anti-inflammatories, immunoglobulins, and antiviral agents.
Conclusions:
- Early detection of myocarditis requires further advancements.
- Distinguishing between viral and autoimmune myocarditis is crucial for targeted therapy.